Body Mass Index (BMI) Dependent Effect of Glucagon Like Peptide 1 Receptor Agonist (GLP-1RA) Therapy on Bowel Preparation Quality

Key Points

• This research aims to evaluate how body mass index (BMI) influences the effectiveness of GLP-1RA therapy on bowel preparation quality.
• Analyzed the effects of GLP-1RA therapy on bowel preparation quality among different BMI categories.
• Stratified patients into normal, overweight, and severe obesity groups for comparison.
• Assessed the incidence of inadequate bowel preparation across these groups.
• Inadequate bowel preparation was notably higher in normal and overweight patients using GLP-1RA.
• Minimal impact on bowel preparation quality was found in severely obese patients.
• BMI stratification offers a framework for tailoring colonoscopy preparation.

Abstract